Brussels, Belgium: 10 March 2026 – Kaneka Ubiquinol, the sole global supplier and pioneer of Ubiquinol, today announced its inaugural Mitochondrial Health Category Sponsorship at Vitafoods Europe 2026 (5-7 May), reinforcing its leadership in one of the fastest-growing dynamic segments in nutraceuticals.
Market analyses indicate that the mitochondrial health and cellular health segment – under the spotlight of global health and medical experts for the essential role in supporting optimal wellbeing protocols across all life stages – is redefining the Healthy Ageing, Women’s Health and Cellular Energy categories, with demand from healthcare practitioners and consumers. The Cellular Health category is expected to reach USD 3,668.1 million by 2035 and have a CAGR of 6.3%.
Often referred to as the body’s cellular “batteries”, mitochondria, powered by Ubiquinol, generate the energy that underpins the major systems in the body - cardiovascular health, cognition, healthy ageing and vitality, women’s health across all life stages, including menopause, reproductive health and optimal wellbeing.
Ubiquinol, the bioactive form of coenzyme Q10 (CoQ10), plays an essential role in cellular energy production and antioxidant protection within this system, with evidence showing the decline in naturally occurring endogenous Ubiquinol from age of 20+.
Recognised globally as a clinically established and foundational ingredient, with 45+ years of research, 100+ studies and 80+ patents, Kaneka Ubiquinol is acknowledged as not simply part of the mitochondrial health category - it is one of the pillars upon which it is built, supporting the science-driven evolution of healthcare at a cellular level.
As the founding Mitochondrial Health Category Sponsor and a trusted Innovation partner to brands worldwide, Kaneka Ubiquinol is leading the next phase of category evolution, ensuring growth is anchored in science, premium quality and long-term brand value creation for its customers.
Marking this milestone, Kaneka Ubiquinol announced the launch of the Kaneka Mitochondrial Innovation Forum - a dedicated 3-day education program at the Kaneka Ubiquinol Pavilion (Hall 3B 102) to build upon Vitafoods Europe’s robust education offering and accelerate its position as a true trusted Innovation Partner for its customers.
The Kaneka Mitochondrial Innovation Forum extends that commitment - equipping partners with the latest scientific data, application insights, go-to-market strategy support and category foresight to convert market momentum into sustained commercial growth.
Daily from 5 – 7 May 2026 at 11 AM, 12 PM, 2 PM, 3:30 PM and 4:30PM internationally recognised market, scientific, innovation and education experts will present the latest clinical advancements and innovation opportunities in mitochondrial function and Ubiquinol including Nick Morgan, Nutrition Integrated; David Foreman, The Herbal Pharmacist; Stephanie Berglin, Nutritionist and Scientific Educator; Jeannie Kwa, Dietician, HCP Educator and CBEC Specialist (Cross Border E-Commerce, China); Ms Yuri Ando, Scientific Affairs Team, KANEKA Corporation.
Marking the announcement of the inaugural Mitochondrial Health Category Sponsorship, Filip Van hulle, General Manager, Kaneka Ubiquinol Europe, said “The Kaneka Mitochondrial Innovation Forum embodies our responsibility as inaugural Mitochondrial Health Category Sponsor. Having maintained a continuous presence at Vitafoods Europe since 2004, this milestone represents the natural progression of more than two decades of leadership in evidence-based ingredient innovation.”
“Leadership in a fast-growing category begins with education. As a trusted Innovation Partner to brands worldwide, our commitment of 45+ years in scientific research and excellence and industry collaboration, is to ensure mitochondrial health continues to grow with integrity, credibility and lasting commercial value for our customers, contributing with real impact to the wellbeing of millions of consumers around the world,” he said.
“Our role extends beyond ingredient supply. We work alongside brands as long-term strategic Innovation Partners, providing the scientific substantiation, quality assurance and market intelligence required to build enduring differentiation in global markets.”
This initiative underscores Kaneka Ubiquinol’s enduring role as:
- The sole global supplier and authority on evidence-based Ubiquinol and a trusted Innovation Partner to brands worldwide
- A recognised benchmark for quality, transparency and scientific rigour
- A proactive steward guiding responsible, profitable category expansion
Industry partners, healthcare professionals and media are invited to attend the Kaneka Mitochondrial Innovation Forum at Vitafoods Europe from 5–7 May 2026 at Stand 3B102.
Further details regarding speakers and session schedules will be released ahead of the event via the Kaneka website.
For meeting requests or Forum program information, please contact:
Kayla Chow, Marketing Specialist – kayla.chow@kaneka.be